HK1009274A1 - Oxidation of steroids having allylic groups - Google Patents

Oxidation of steroids having allylic groups

Info

Publication number
HK1009274A1
HK1009274A1 HK98109869A HK98109869A HK1009274A1 HK 1009274 A1 HK1009274 A1 HK 1009274A1 HK 98109869 A HK98109869 A HK 98109869A HK 98109869 A HK98109869 A HK 98109869A HK 1009274 A1 HK1009274 A1 HK 1009274A1
Authority
HK
Hong Kong
Prior art keywords
allylic
steroids
oxidation
allylic groups
delta
Prior art date
Application number
HK98109869A
Other languages
English (en)
Inventor
Ross A Miller
Andrew S Thompson
Raman K Bakshi
Edward G Corley
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK1009274A1 publication Critical patent/HK1009274A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • B01J23/462—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/652—Chromium, molybdenum or tungsten
    • B01J23/6527—Tungsten
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98109869A 1994-05-19 1998-08-12 Oxidation of steroids having allylic groups HK1009274A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24593594A 1994-05-19 1994-05-19
PCT/US1995/006004 WO1995032215A1 (en) 1994-05-19 1995-05-15 Oxidation of steroids having allylic groups

Publications (1)

Publication Number Publication Date
HK1009274A1 true HK1009274A1 (en) 1999-05-28

Family

ID=22928693

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109869A HK1009274A1 (en) 1994-05-19 1998-08-12 Oxidation of steroids having allylic groups

Country Status (23)

Country Link
US (1) US6369247B1 (xx)
EP (1) EP0759929B1 (xx)
JP (1) JPH10500682A (xx)
KR (1) KR970703359A (xx)
CN (1) CN1152316A (xx)
AT (1) ATE195741T1 (xx)
AU (1) AU688513B2 (xx)
BR (1) BR9507663A (xx)
CA (1) CA2190500A1 (xx)
CZ (1) CZ338896A3 (xx)
DE (1) DE69518515T2 (xx)
DK (1) DK0759929T3 (xx)
ES (1) ES2149365T3 (xx)
FI (1) FI964610A0 (xx)
GR (1) GR3034201T3 (xx)
HK (1) HK1009274A1 (xx)
HU (1) HU223613B1 (xx)
NZ (1) NZ287230A (xx)
PT (1) PT759929E (xx)
RO (1) RO116550B1 (xx)
RU (1) RU2149875C1 (xx)
SK (1) SK282278B6 (xx)
WO (1) WO1995032215A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862556B1 (en) * 1995-10-23 2001-09-05 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US5869709A (en) * 1997-05-07 1999-02-09 Humanetics Corporation Process for effecting allylic oxidation
US6686486B1 (en) 1997-05-07 2004-02-03 Padma Marwah Process for effecting allylic oxidation
US6252119B1 (en) * 1997-07-28 2001-06-26 Salvador Jorge Antonio Riberiro Copper-catalysed allylic oxidation using alkyl hydroperoxide
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
US6384251B1 (en) 1998-03-18 2002-05-07 Humanetics Corporation Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents
AU775630B2 (en) 1999-04-30 2004-08-05 Arch Development Corporation Steroid derivatives
GB0020286D0 (en) * 2000-08-18 2000-10-04 Univ York Cobalt catalysed allylic oxidation of unsaturated steroids using alkyl hydroperoxide
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
PT1392713E (pt) * 2001-05-03 2008-01-25 Univ Chicago ''agonistas de receptores x hepáticos''
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
WO2003086303A2 (en) * 2002-04-12 2003-10-23 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20060204530A1 (en) * 2005-03-10 2006-09-14 Jr Chem, Llc Benzoyl peroxide compositions and methods of use
KR101352187B1 (ko) * 2005-03-10 2014-02-17 제이알 켐, 엘엘씨 안정한 유기 퍼옥사이드 조성물
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
US20070044810A1 (en) * 2005-06-29 2007-03-01 Jr Chem, Llc Method of enhanced drug application
CN101619089B (zh) * 2009-07-28 2011-07-20 陈大刚 抗肿瘤药物cl168、其合成方法及应用
JP2013500986A (ja) * 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
CN103338861B (zh) * 2011-01-31 2016-04-13 旭化成化学株式会社 混合液制造装置及混合液制备方法
US9828326B2 (en) 2011-12-27 2017-11-28 Northeast Ohio Medical University Amooranin compounds and analogs thereof and related methods of use
KR20160058722A (ko) * 2013-03-15 2016-05-25 더 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 ent-프로게스테론 및 그의 중간생성물의 합성
CN103788163B (zh) * 2014-01-27 2015-11-18 浙江大学 7-酮基甾类化合物的制备方法
US10730821B2 (en) 2015-11-23 2020-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
CN106008423B (zh) * 2016-06-24 2018-02-02 云南民族大学 一种苯丙素类化合物及其制备方法和应用
JP2023514711A (ja) 2020-02-21 2023-04-07 レトロトップ、 インコーポレイテッド 多価不飽和脂肪酸及びその誘導体の同位体修飾方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422443D0 (en) 1984-09-05 1984-10-10 British Petroleum Co Plc Oxidation of hydrocarbons
DK173704B1 (da) 1985-04-17 2001-07-09 Hoffmann La Roche Fremgangsmåde til katalytisk oxidation af allyliske grupper
RU94046044A (ru) * 1992-05-20 1996-10-10 Мерк Энд Ко. Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
IL111467A0 (en) 1993-11-12 1994-12-29 Merck & Co Inc Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Also Published As

Publication number Publication date
DE69518515D1 (de) 2000-09-28
GR3034201T3 (en) 2000-11-30
EP0759929B1 (en) 2000-08-23
AU2588595A (en) 1995-12-18
ES2149365T3 (es) 2000-11-01
CZ338896A3 (en) 1997-07-16
DK0759929T3 (da) 2000-11-13
US6369247B1 (en) 2002-04-09
BR9507663A (pt) 1997-10-07
AU688513B2 (en) 1998-03-12
JPH10500682A (ja) 1998-01-20
CA2190500A1 (en) 1995-11-30
HU9603187D0 (en) 1997-01-28
HUT75778A (en) 1997-05-28
EP0759929A1 (en) 1997-03-05
FI964610A (fi) 1996-11-18
NZ287230A (en) 1997-07-27
DE69518515T2 (de) 2001-04-19
SK147896A3 (en) 1997-08-06
ATE195741T1 (de) 2000-09-15
EP0759929A4 (en) 1998-09-30
RO116550B1 (ro) 2001-03-30
HU223613B1 (hu) 2004-10-28
RU2149875C1 (ru) 2000-05-27
FI964610A0 (fi) 1996-11-18
KR970703359A (ko) 1997-07-03
CN1152316A (zh) 1997-06-18
SK282278B6 (sk) 2002-01-07
PT759929E (pt) 2001-01-31
WO1995032215A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
HK1009274A1 (en) Oxidation of steroids having allylic groups
AU3030997A (en) Oxidation catalyst and process for the production of epoxides from olefines, hydrogen and oxygen using said oxidation catalyst
TW342353B (en) Process for the regeneration of catalysts
AU5119198A (en) Preparation of hydrogen peroxide
AU556055B2 (en) Treating peroxide containing wastewater
EP0764464A3 (en) Catalyst for production of ethylene oxide
ATE212612T1 (de) Verfahren zur oxidation einer mindestens eine c-c-doppelbindung aufweisenden organischen verbindung
ES8402797A1 (es) "un procedimiento para obtener peroxido de hidrogeno".
AU3093197A (en) Process for producing epoxides from olefines and hydrogen peroxide or hydroperoxides using a zeolithic oxidation catalyst
TW429163B (en) Oxidazing catalyst system and an oxidation process by using the same
ES8604467A1 (es) Un metodo catalitico mejorado para preparar peroxido de hidrogeno
DE69402556D1 (de) Herstellung von n-phosphonomethylglysin und derensalze
MX9605718A (es) Oxidacion de esteroides que tienen grupos alilicos.
ES2114179T3 (es) Oxidacion de cetonas.
AU630289B2 (en) Process for the production of alkyltetrahydroanthrahydroquinones and working solutions containing the latter for the production of hydrogen peroxide according to the anthraquinone process
ZA801550B (en) Process for freeing phosphoric acid from organic contaminants
KR890012959A (ko) 3-(2-히드로페록시-2-프로필)페놀 및 이를 이용한 레조르시놀의 제조 방법
EP0839760A3 (en) Production process of hydrogen peroxide by oxidation of secondary alcohols with molecular oxygen in liquid phase
BR9711433A (pt) Catalisador de prata ativado
ES314231A1 (es) Procedimiento para la elaboracion de subestratos oxidados.
EP0159755A3 (en) Isomerization of tertiary olefins
GB9727117D0 (en) Process for the oxidation of olefins to olefin oxides
IT8720702A0 (it) Procedimento di ottenimento di metilbutiletereterziario e di supercarburante a partire da butani e/o da frazioni a quattro atomi di carbonio provenienti da una scissione o da un reformingcatalitico.
ATE39476T1 (de) Oxydation von ungesaettigten organischen verbindungen durch wasserstoffperoxyd.
UA32517C2 (uk) Каталізатор для одержання вінілацетату

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040515